Dr. Daniel M. Hume, MD

Dr. Hume practices at AdventHealth Home Infusion West Florida in Thonotosassa, Florida.

Dr. Hume's NPI, 1629062864, was assigned on September 2, 2005. Dr. Hume graduated from University Of Michigan Medical School in 1997. Dr. Hume holds Florida license ME76618.

Dr. Hume's primary practice is AdventHealth Home Infusion West Florida, at 11461 N Us-301, Thonotosassa, FL 33592 in Hillsborough County. The practice phone is (407) 660-1122.

Dr. Hume's primary practice is AdventHealth Home Infusion West Florida in Thonotosassa, Florida. Dr. Hume is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Suncoast Inpatient Care P A. Dmand AI also links Dr. Hume to 5 more hospitals and 4 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hume practices, 10 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Hume's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Hume is licensed in Florida.

CMS data shows 4,432 Medicare services from Dr. Hume across 5 procedure codes in 2024, for 1,618 Medicare patients. Medicare paid $277,158 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,618 Medicare patients who saw Dr. Hume in 2024. The largest group is 75 to 84, with 681 patients. 75% of them have arthritis, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hume's median patient age at 79, with 44% women.

In 2024, Dr. Hume wrote 2,526 Medicare Part D claims for 390 patients. 90% of them were for generic drugs. CMS names the drug for 1,983 of them, across 63 drugs with 11 or more claims each, at $82,858 in total drug cost. In 2023, CMS named 2,099 claims across 71 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Hume for performance year 2024, reported individually. Dr. Hume accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Hume from 2 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $28.

Dr. Hume graduated from University Of Michigan Medical School in 1997.

Dr. Hume is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.